GSK3β inhibition protects the immature brain from hypoxic-ischaemic insult via reduced STAT3 signalling.

D'Angelo, Barbara

GSK3β inhibition protects the immature brain from hypoxic-ischaemic insult via reduced STAT3 signalling. [electronic resource] - Neuropharmacology Feb 2016 - 13-23 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

1873-7064

10.1016/j.neuropharm.2015.09.017 doi


Animals
Animals, Newborn
Brain--drug effects
Brain Infarction--etiology
Caspase 3--metabolism
Cerebrovascular Circulation--drug effects
Disease Models, Animal
Doublecortin Domain Proteins
Drug Administration Schedule
Enzyme Inhibitors--therapeutic use
Glycogen Synthase Kinase 3--antagonists & inhibitors
Glycogen Synthase Kinase 3 beta
Hippocampus--pathology
Hypoxia-Ischemia, Brain--drug therapy
Indoles--therapeutic use
Maleimides--therapeutic use
Mice
Mice, Inbred C57BL
Microtubule-Associated Proteins--metabolism
Nerve Tissue Proteins--metabolism
Neuropeptides--metabolism
STAT3 Transcription Factor--genetics
Stem Cells--drug effects
Subcellular Fractions--drug effects